Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
Zika virus caught the world by surprise by its rapid spread and frightening disease outcomes. This major epidemic motivated many scientists to focus their attention on controlling this emerging pathogen. As many as 45 vaccine candidates are being developed, but progress in the antiviral arena has be...
Main Authors: | Devika Sirohi, Richard J. Kuhn |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2017-06-01
|
Series: | mBio |
Online Access: | http://mbio.asm.org/cgi/content/full/8/3/e00916-17 |
Similar Items
-
Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
by: Dr. Chenshu Xu, et al.
Published: (2021-09-01) -
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
by: Becky A. S. Bibby, et al.
Published: (2021-07-01) -
Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
by: Ashwini eBenedict, et al.
Published: (2015-07-01) -
Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
by: Matthew Cannon, et al.
Published: (2020-07-01) -
Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats
by: Zulfiqar Z, et al.
Published: (2020-12-01)